NCT01918475View on ClinicalTrials.gov

Analgesic Effect of Oxytocin Receptor Modulation

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
PainHyperalgesiaCentral Sensitization
Interventions
DRUG

Carbetocin

Carbetocin 0.1 mg single dose is intravenously administered

DRUG

Placebo

1ml of NaCl 0.9% is administered intravenously

Trial Locations (1)

3010 Bern

University Department of Anesthesiology and Pain Therapy, Bern University Hospital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT01918475 - Analgesic Effect of Oxytocin Receptor Modulation | Biotech Hunter | Biotech Hunter